We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
(+5.9%)
Cap. Flow
+$49.6M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$57.1M |
| 2 |
Federal Realty Investment Trust
FRT
|
+$54.9M |
| 3 |
New Jersey Resources
NJR
|
+$10.3M |
| 4 |
Medtronic
MDT
|
+$10.1M |
| 5 |
UMB Financial
UMBF
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthpeak Properties
DOC
|
+$48.2M |
| 2 |
CLC
Clarcor
CLC
|
+$15.4M |
| 3 |
Amgen
AMGN
|
+$11.3M |
| 4 |
Apple
AAPL
|
+$9.79M |
| 5 |
Nucor
NUE
|
+$8.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.52% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.08% |
| 4 | Consumer Staples | 11.47% |
| 5 | Industrials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Core Laboratories
CLB
$538M
| $439K | ﹤0.01% |
3,802
+297
| +8% | +$34.5K |
|
|
ITCI
1052
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $439K | ﹤0.01% |
27,045
-7,053
| -21% | -$102K |
|
|
IMMU
1053
DELISTED
Immunomedics Inc
IMMU
| $439K | ﹤0.01% |
67,831
-17,807
| -21% | -$90.2K |
|
|
CVSA
1054
Covista Inc
CVSA
$3.94B
| $438K | ﹤0.01% |
12,364
-3,686
| -23% | -$122K |
|
1055
Molina Healthcare
MOH
$10.3B
| $438K | ﹤0.01% |
9,609
-2,148
| -18% | -$112K |
|
|
SEMG
1056
DELISTED
SEMGROUP CORPORATION
SEMG
| $438K | ﹤0.01% |
12,174
-2,655
| -18% | -$101K |
|
1057
Bio-Rad Laboratories Class A
BIO
$8.42B
| $437K | ﹤0.01% |
2,190
-136
| -6% | -$26.2K |
|
1058
Semtech
SMTC
$11.7B
| $437K | ﹤0.01% |
12,935
-2,746
| -18% | -$92.2K |
|
|
HRC
1059
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $437K | ﹤0.01% |
6,187
-417
| -6% | -$26.5K |
|
|
LUMO
1060
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $435K | ﹤0.01% |
2,004
-521
| -21% | -$74.4K |
|
1061
PRA Group
PRAA
$648M
| $434K | ﹤0.01% |
13,091
-1,543
| -11% | -$57.9K |
|
1062
Universal Display
OLED
$3.71B
| $433K | ﹤0.01% |
5,033
-1,860
| -27% | -$134K |
|
|
TEN
1063
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $432K | ﹤0.01% |
6,920
-2,598
| -27% | -$170K |
|
|
INSY
1064
DELISTED
Insys Therapeutics, Inc.
INSY
| $431K | ﹤0.01% |
41,009
-10,179
| -20% | -$108K |
|
|
KS
1065
DELISTED
KapStone Paper and Pack Corp.
KS
| $431K | ﹤0.01% |
18,644
-3,816
| -17% | -$88.1K |
|
1066
SM Energy
SM
$7.96B
| $430K | ﹤0.01% |
17,886
-712
| -4% | -$19.7K |
|
|
KDNY
1067
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $429K | ﹤0.01% |
7,988
-2,028
| -20% | -$115K |
|
1068
Amphastar Pharmaceuticals
AMPH
$825M
| $428K | ﹤0.01% |
29,498
-7,423
| -20% | -$117K |
|
1069
Zebra Technologies
ZBRA
$12.4B
| $427K | ﹤0.01% |
4,682
-660
| -12% | -$57.2K |
|
1070
Pool Corp
POOL
$6.7B
| $426K | ﹤0.01% |
3,573
-557
| -13% | -$62.4K |
|
1071
Papa John's
PZZA
$999M
| $426K | ﹤0.01% |
5,320
-1,600
| -23% | -$130K |
|
|
PFPT
1072
DELISTED
Proofpoint, Inc.
PFPT
| $426K | ﹤0.01% |
5,725
-1,742
| -23% | -$138K |
|
|
THS
1073
DELISTED
Treehouse Foods
THS
| $425K | ﹤0.01% |
5,025
-701
| -12% | -$56.2K |
|
1074
Chemed
CHE
$6.78B
| $424K | ﹤0.01% |
2,320
-719
| -24% | -$125K |
|
1075
NovoCure
NVCR
$2.04B
| $424K | ﹤0.01% |
52,305
-13,162
| -20% | -$95K |
|
Similar funds
ProShare Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
- ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
- ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
- ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
- ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
- ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.
Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.